Print Page | Contact Us | Sign In | Register
News & Press: Member News

KCK pharma startup: We want to be the next Marion Labs

Monday, August 28, 2017   (0 Comments)
Posted by: Dennis Ridenour
Share |

Cingulate Therapeutics’ co-founders are bringing Kauffman-sized aspirations as they close clinical trials on their first two products. The Kansas City, Kan., pharmaceutical company is focused on creating the ideal ADHD treatment with its first two products.  READ MORE....

From Elise Reuter, KCBJ